The GLP-1 receptor agonist liraglutide was able to reduce Bax expression in pancreatic cells from T2DM rats, and Bcl-2 expression was increased, islet tissue structure was improved, insulin-positive expression was increased, and -cell apoptosis was reduced (Liu et al., 2021)
On the other hand, dry mouth, nutritional deficiencies, and reduced oral hygiene can offset these benefits
Women use GLP-1s at higher rates than men, particularly those aged 5064.4 Among individuals aged 3049, women are more than twice as likely as men to have used the drugs
Gluckman, those are some of the reasons this research is so important
News Release: Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
Everything arrived cold